These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7659589)

  • 1. Sensing failure in a tiered therapy implantable cardioverter defibrillator: role of auto adjustable gain.
    Wase A; Natale A; Dhala AA; Deshpande S; Sra JS; Blanck Z; Maglio C; Jazayeri MR; Akhtar M
    Pacing Clin Electrophysiol; 1995 Jun; 18(6):1327-30. PubMed ID: 7659589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undersensing of ventricular fibrillation due to interference between a pacemaker and defibrillator in the same patient.
    Van Casteren L; Huybrechts W; Willems R
    Europace; 2009 Oct; 11(10):1390-1. PubMed ID: 19654130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of a second and third generation implantable cardioverter defibrillator to sense ventricular tachycardia: implications for fixed-gain sensing devices.
    Sperry RE; Ellenbogen KA; Wood MA; Stambler BS; DiMarco JP; Haines DE
    Pacing Clin Electrophysiol; 1992 May; 15(5):749-55. PubMed ID: 1382277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spurious redetection of sinus rhythm by an implantable cardioverter defibrillator during spontaneous ventricular fibrillation.
    Otto L; Mann DE; Kelly PA; Reiter MJ
    Pacing Clin Electrophysiol; 1999 Oct; 22(10):1550-2. PubMed ID: 10588160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Undersensing during ventricular tachyarrhythmias in a third-generation implantable cardioverter defibrillator: diagnosis using stored electrograms and correction with programming.
    Mann DE; Kelly PA; Damle RS; Reiter MJ
    Pacing Clin Electrophysiol; 1994 Sep; 17(9):1525-30. PubMed ID: 7991424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Delayed detection of ventricular tachycardia due to intradevice interactions by implantable atrio-ventricular pacer/cardioverter defibrillator.
    Kantharia BK; Padder FA
    J Interv Card Electrophysiol; 2006 Aug; 16(2):135-8. PubMed ID: 17016683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pacing induced ventricular fibrillation in internal cardioverter defibrillator patients: a new form of proarrhythmia.
    Vlay LC; Vlay SC
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):132-3. PubMed ID: 9121960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bradycardia pacing caused by far-field atrial sensing in a third-generation cardioverter defibrillator with an automatic gain feature.
    Curwin JH; Roelke M; Ruskin JN
    Pacing Clin Electrophysiol; 1996 Jan; 19(1):124-6. PubMed ID: 8848369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillator: present and future indications.
    Block M; Scheld H; Breithardt G
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate discharges of an implantable cardioverter defibrillator secondary to automatic adjustable gain of atrial tachycardia.
    Schecter SO; Greenberg SM; Hoch DH; Cesa M; Levine JH
    Pacing Clin Electrophysiol; 1997 Jun; 20(6):1721-2. PubMed ID: 9227775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the necessity of the invasive predischarge test after implantation of a cardioverter-defibrillator.
    Wieckhorst A; Buchwald A; Unterberg C
    Am J Cardiol; 1998 Apr; 81(7):933-5. PubMed ID: 9555788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular pacing induced ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Roelke M; O'Nunain S; Osswald S; Trouton TG; Harthorne JW; Garan H; Ruskin JN
    Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 1):486-91. PubMed ID: 7770372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive Periodic Atrial Oversensing in a Cardiac Implantable Electrical Defibrillator at 35 Minutes and 50 Minutes Past the Hour: What Is the Diagnosis?
    Hu YL; Kaszala K; Huizar J; Ellenbogen KA; Tan AY
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):1018-21. PubMed ID: 27356808
    [No Abstract]   [Full Text] [Related]  

  • 17. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Van Gelder BM; Meijer A; Dekker LR; Bracke FA
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective left ventricular sensing lead implantation to overcome undersensing of ventricular fibrillation during implantable cardioverter defibrillator implantation.
    Steinberg C; Philippon F; O'Hara G; Molin F
    Can J Cardiol; 2013 Jun; 29(6):751.e3-6. PubMed ID: 23395280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.